NCT01157325

Brief Summary

Currently, it is certain that neuraxial analgesia in early stage of labor and delivery dose not increase the risk of Cesarean section. However, given ethical reasons, whether such a medical procedure could increase the Cesarean rate compared with those who did not received neuraxial analgesia or not is yet to be known. It is difficult to perform such a study in occidental countries because they have a higher rate of labor analgesia. On the contrary, the rate of labor analgesia in China is up to date only 1%, so it can be done easily. The investigators hypothesized that no neuraxial analgesia itself were a risk factor to Cesarean section. Therefore, the investigators design this study to compared the effect of neuraxial analgesia on the rate of Cesarean delivery with those who did not received neuraxial analgesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2010

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

July 6, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 7, 2010

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2011

Completed
Last Updated

July 27, 2011

Status Verified

July 1, 2011

Enrollment Period

1 year

First QC Date

July 6, 2010

Last Update Submit

July 26, 2011

Conditions

Keywords

Epidural analgesiaLatent analgesiaActive analgesiaCesarean section

Outcome Measures

Primary Outcomes (1)

  • Cesarean rate

    Rate of Cesarean delivery in both neuraxial and non-neuraxial analgesia women

    One day after birth

Secondary Outcomes (9)

  • Instrumental delivery

    One day after birth

  • VAS pain intensity

    At the begining of labor (0 min)

  • VAS pain intensity

    At the cervix 10 cm (This time may be subjected to change in different patients)

  • VAS pain intensity

    2h after cervix 10 cm

  • Time of successful labor

    From the initial of labor (0 min) to completion of delivery (this is changable individually)

  • +4 more secondary outcomes

Study Arms (2)

Non-neuraxial analgesia

ACTIVE COMPARATOR

Parturients will not receive neuraxial analgesia

Procedure: Non-neuraxial analgesia

Neuraxial analgesia

ACTIVE COMPARATOR

Parturients will receive neuraxial analgesia

Procedure: Neuraxial analgesia

Interventions

Neuraxial analgesia will be given at any time if the parturient requested analgesia

Neuraxial analgesia

No neuraxial analgesia will be given to those who will not want to an analgesia

Non-neuraxial analgesia

Eligibility Criteria

Age19 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age \>= 19yr, \<=40 yr
  • Height 140 - 170 cm
  • Singleton pregnancy
  • Uncomplicated pregnancy
  • Chinese

You may not qualify if:

  • Multiple gestations
  • Pregnancy-induced hypertension
  • Diabetes mellitus
  • Chronic pain
  • Allergic to opioids and/or local anesthetics
  • Failed to performing inter lumbar space catheterization
  • Organic dysfunction
  • Contraindications for neuraxial analgesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nanjing Maternity and Child Health Care Hospital

Nanjing, Jiangsu, 210004, China

Location

Study Officials

  • XiaoFeng Shen, MD, MPH

    Nanjing Medical University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 6, 2010

First Posted

July 7, 2010

Study Start

July 1, 2010

Primary Completion

July 1, 2011

Study Completion

July 1, 2011

Last Updated

July 27, 2011

Record last verified: 2011-07

Locations